PhoenixBio Competitors and Similar CompaniesClear all

PhoenixBio's competitors and similar companies include FibroGen and CanSino Biologics.
PhoenixBio
PhoenixBio
PhoenixBio (株式会社フェニックスバイオ) is a company that provides contract study services for drug discovery and development.
FibroGen
FibroGen
FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.
CanSino Biologics
CanSino Biologics
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
Founding Date
Founding Date
2002
Founding Date
1993
Founding Date
2009
Type
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Higashihiroshima, JP HQ
New York, US
Locations
San Francisco, US HQ
Locations
Tianjin, CN HQ
Employees
Employees
70
Employees
53115% increase
Employees
1,10526% decrease
Valuation ($)
Valuation ($)
10.9 m
Valuation ($)
30.7 m
Valuation ($)
N/A

Financial

Revenue (est.)
Revenue (est.)
¥1.6b (FY, 2026)
Revenue (est.)
$6.4m (FY, 2025)
Revenue (est.)
¥1.1b (FY, 2025)
Cost of goods
Cost of goods
¥342.7m (FY, 2026)
Cost of goods
$556k (FY, 2025)
Cost of goods
¥81.4m (FY, 2025)
Gross profit
Gross profit
¥1.2b (FY, 2026)
Gross profit
$5.9m (FY, 2025)
Gross profit
¥1.1b (FY, 2025)
Net income
Net income
¥125.2m (FY, 2026)
Net income
$183.5m (FY, 2025)
Net income
¥27.9m (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

FibroGen
HQ
San Francisco, US
Employees
531↑ 15% increase

FibroGen is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical needs.

View company
CanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease

CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.

View company